A Review of Next-Generation Therapeutics and Contemporary Management of Myelofibrosis

Download All
Learn from expert faculty as they discuss recent and emerging data in myelofibrosis in a downloadable slideset from a satellite symposium and an on-demand webcast.
Srdan Verstovsek, MD, PhD
Program Director
Brady L. Stein, MD, MHS
person default
Abdulraheem Yacoub, MD

Downloadable Slidesets

Download this slideset from a live symposium at ASH 2022 to review diagnostic considerations with MPNs and risk stratification for patients with MF.

Brady L. Stein, MD, MHS Released: December 9, 2022

Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients who are newly diagnosed with myelofibrosis.

Srdan Verstovsek, MD, PhD
Program Director
Released: December 9, 2022

Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients with myelofibrosis who have received previous therapies (including ruxolitinib).

person default Abdulraheem Yacoub, MD Released: December 9, 2022

Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in managing patients with MF.

Srdan Verstovsek, MD, PhD
Program Director
Brady L. Stein, MD, MHS person default Abdulraheem Yacoub, MD
Released: December 16, 2022

On-Demand Webcast

Watch this on-demand webcast from an ASH satellite symposium on the use of current and emerging therapies for patients with myelofibrosis, including discussions on individualized treatment plans, treatment for relapsed/refractory disease, managing treatment-related toxicities, and clinical trials.

Srdan Verstovsek, MD, PhD
Program Director
Brady L. Stein, MD, MHS person default Abdulraheem Yacoub, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: December 20, 2022 Expired: December 19, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
CTI Biopharma

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings